Enerplus Corp.
Enerplus Corp. (NYSE: ERF), relating to its proposed merger with Chord Energy Corp. Under the terms of the agreement, ERF shareholders are expected to receive 0.10125 shares of Chord plus $1.84 in cash per share they own.
Enerplus Corp. (NYSE: ERF), relating to its proposed merger with Chord Energy Corp. Under the terms of the agreement, ERF shareholders are expected to receive 0.10125 shares of Chord plus $1.84 in cash per share they own.
Diamondback Energy, Inc. (Nasdaq: FANG), relating to its proposed merger with Endeavor Energy Resources L.P. Under the terms of the agreement, FANG shareholders are expected to own approximately 60.5% of the combined company.
CymaBay Therapeutics, Inc. (Nasdaq: CBAY), relating to its proposed sale to Gilead Sciences, Inc. Under the terms of the agreement, CBAY shareholders will receive $32.50 in cash per share they own.
Assure Holdings Corp. (Nasdaq: IONM), relating to its proposed merger with Danam Health, Inc. Under the terms of the agreement, Assure shareholders are expected to own approximately 10% of the combined company.
ContextLogic, Inc. (Nasdaq: WISH), relating to its proposed sale to Qoo10. Under the terms of the agreement, WISH shareholders will receive $6.50 in cash per share they own.
Fresh Vine Wine Inc. (NYSE: VINE), relating to its proposed sale to Notes Live, Inc.
McGrath RentCorp (Nasdaq: MGRC), relating to its proposed sale to WillScot Mobile Mini Holdings Corp. Under the terms of the agreement, MGRC shareholders will receive either $123.00 in cash or 2.8211 shares of WillScot per share they own.
California BanCorp (NASDAQ: CALB), relating to its proposed merger with Southern California Bancorp. Under the terms of the agreement, California BanCorp shareholders will own approximately 42.9% of outstanding shares of the combined company.
AVROBIO, Inc. (Nasdaq: AVRO), relating to its proposed merger with Tectonic Therapeutic, Inc. Under the terms of the agreement, AVRO shareholders are expected to own approximately 22.3% of the combined company.
Science 37 Holdings, Inc. (Nasdaq: SNCE), relating to its proposed sale to eMed, LLC. Under the terms of the agreement, SNCE shareholders will receive $5.75 in cash per share they own.